396 related articles for article (PubMed ID: 31067538)
1. Effects of Proton Pump Inhibitor on the Distribution of Helicobacter pylori and Associated Gastritis in Patients with Gastric Atrophy.
Gong EJ; Kim DH; Ahn JY; Na HK; Jung KW; Lee JH; Choi KD; Song HJ; Lee GH; Jung HY; Park Y; Kim MJ
Digestion; 2020; 101(3):279-286. PubMed ID: 31067538
[TBL] [Abstract][Full Text] [Related]
2. Treatment with a proton pump inhibitor promotes corpus gastritis in patients with Helicobacter pylori-infected antrum-predominant gastritis.
Suzuki M; Suzuki H; Kitahora T; Miyazawa M; Nagahashi S; Suzuki K; Ishii H
Aliment Pharmacol Ther; 2002 Jan; 16(1):159-65. PubMed ID: 11856091
[TBL] [Abstract][Full Text] [Related]
3. Gastric phenotype in children with Helicobacter pylori infection undergoing upper endoscopy.
Hoepler W; Hammer K; Hammer J
Scand J Gastroenterol; 2011 Mar; 46(3):293-8. PubMed ID: 21073375
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of gastritis in patients with Helicobacter pylori-positive reflux esophagitis.
Mihara T; Adachi K; Komazawa Y; Yoshida M; Araki A; Maruyama R; Furuta K; Ishihara S; Amano Y; Kinoshita Y
J Gastroenterol Hepatol; 2005 May; 20(5):682-7. PubMed ID: 15853979
[TBL] [Abstract][Full Text] [Related]
5. Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes.
Nasser SC; Slim M; Nassif JG; Nasser SM
World J Gastroenterol; 2015 Apr; 21(15):4599-606. PubMed ID: 25914469
[TBL] [Abstract][Full Text] [Related]
6. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety.
Kuipers EJ; Uyterlinde AM; Peña AS; Hazenberg HJ; Bloemena E; Lindeman J; Klinkenberg-Knol EC; Meuwissen SG
Am J Gastroenterol; 1995 Sep; 90(9):1401-6. PubMed ID: 7661157
[TBL] [Abstract][Full Text] [Related]
7. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during long-term acid-suppressive treatment in Japan.
Uemura N; Okamoto S; Yamamoto S; Matsumura N; Yamaguchi S; Mashiba H; Sasaki N; Taniyama K
Aliment Pharmacol Ther; 2000 Oct; 14(10):1345-52. PubMed ID: 11012481
[TBL] [Abstract][Full Text] [Related]
8. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?
Xia HH; Kalantar JS; Talley NJ; Wyatt JM; Adams S; Chueng K; Mitchell HM
Am J Gastroenterol; 2000 Jan; 95(1):114-21. PubMed ID: 10638568
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use.
Parsons BN; Ijaz UZ; D'Amore R; Burkitt MD; Eccles R; Lenzi L; Duckworth CA; Moore AR; Tiszlavicz L; Varro A; Hall N; Pritchard DM
PLoS Pathog; 2017 Nov; 13(11):e1006653. PubMed ID: 29095917
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of IL-1β and TNF-α polymorphisms on the H. pylori-related gastric pre-malignant condition.
Tahara T; Shibata T; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Kamiya Y; Ishizuka T; Nakagawa Y; Nagasaka M; Iwata M; Nakamura M; Hirata I; Arisawa T
Hepatogastroenterology; 2012; 59(120):2416-20. PubMed ID: 23169178
[TBL] [Abstract][Full Text] [Related]
11. Atrophic gastritis in young children and adolescents.
Ricuarte O; Gutierrez O; Cardona H; Kim JG; Graham DY; El-Zimaity HM
J Clin Pathol; 2005 Nov; 58(11):1189-93. PubMed ID: 16254110
[TBL] [Abstract][Full Text] [Related]
12. Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated.
Ohkusa T; Fujiki K; Takashimizu I; Kumagai J; Tanizawa T; Eishi Y; Yokoyama T; Watanabe M
Ann Intern Med; 2001 Mar; 134(5):380-6. PubMed ID: 11242498
[TBL] [Abstract][Full Text] [Related]
13. Gastric mucosal changes, and sex differences therein, after Helicobacter pylori eradication: A long-term prospective follow-up study.
Kodama M; Okimoto T; Mizukami K; Hirashita Y; Wada Y; Fukuda M; Matsunari O; Okamoto K; Ogawa R; Fukuda K; Kudo Y; Kawahara Y; Murakami K
J Gastroenterol Hepatol; 2021 Aug; 36(8):2210-2216. PubMed ID: 33656793
[TBL] [Abstract][Full Text] [Related]
14. Treatment of
Lahner E; Carabotti M; Annibale B
World J Gastroenterol; 2018 Jun; 24(22):2373-2380. PubMed ID: 29904244
[No Abstract] [Full Text] [Related]
15. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study.
Kyzekova J; Mour J
Hepatogastroenterology; 1999; 46(27):2048-56. PubMed ID: 10430396
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Helicobacter pylori infection and gastric mucosal histological features of gastric ulcer patients with chronic gastritis patients.
Zhang C; Yamada N; Wu YL; Wen M; Matsuhisa T; Matsukura N
World J Gastroenterol; 2005 Feb; 11(7):976-81. PubMed ID: 15742399
[TBL] [Abstract][Full Text] [Related]
17. Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study.
Toyokawa T; Suwaki K; Miyake Y; Nakatsu M; Ando M
J Gastroenterol Hepatol; 2010 Mar; 25(3):544-7. PubMed ID: 19817964
[TBL] [Abstract][Full Text] [Related]
18. High expression of Helicobacter pylori VapD in both the intracellular environment and biopsies from gastric patients with severity.
Morales-Espinosa R; Delgado G; Serrano LR; Castillo E; Santiago CA; Hernández-Castro R; Gonzalez-Pedraza A; Mendez JL; Mundo-Gallardo LF; Manzo-Merino J; Ayala S; Cravioto A
PLoS One; 2020; 15(3):e0230220. PubMed ID: 32163505
[TBL] [Abstract][Full Text] [Related]
19. Immune response to Helicobacter pylori and its association with the dynamics of chronic gastritis in the antrum and corpus.
Vorobjova T; Maaroos HI; Uibo R
APMIS; 2008 Jun; 116(6):465-76. PubMed ID: 18754320
[TBL] [Abstract][Full Text] [Related]
20. Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis.
Sanduleanu S; Jonkers D; De Bruïne A; Hameeteman W; Stockbrügger RW
Aliment Pharmacol Ther; 2001 Aug; 15(8):1163-75. PubMed ID: 11472319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
